First Time Loading...

Quanterix Corp
NASDAQ:QTRX

Watchlist Manager
Quanterix Corp Logo
Quanterix Corp
NASDAQ:QTRX
Watchlist
Price: 18.37 USD -7.92% Market Closed
Updated: Apr 13, 2024

Intrinsic Value

QTRX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. [ Read More ]

The intrinsic value of one QTRX stock under the Base Case scenario is 26.58 USD. Compared to the current market price of 18.37 USD, Quanterix Corp is Undervalued by 31%.

Key Points:
QTRX Intrinsic Value
Base Case
26.58 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Quanterix Corp

Backtest QTRX Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling QTRX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Quanterix Corp

What is the historical net income growth
over the last 5 years for Quanterix Corp?

Show all profitability ratios
for Quanterix Corp.

Show me price targets
for Quanterix Corp made by professional analysts.

What is the current Free Cash Flow
of Quanterix Corp?

AI Assistant can make mistakes. Consider checking important information.
Financials

Balance Sheet Decomposition
Quanterix Corp

Current Assets 378.4m
Cash & Short-Term Investments 321.3m
Receivables 25.4m
Other Current Assets 31.7m
Non-Current Assets 46.6m
PP&E 36.2m
Intangibles 6m
Other Non-Current Assets 4.4m
Current Liabilities 38.5m
Accounts Payable 5m
Accrued Liabilities 23.9m
Other Current Liabilities 9.5m
Non-Current Liabilities 39.6m
Other Non-Current Liabilities 39.6m
Efficiency

Earnings Waterfall
Quanterix Corp

Revenue
122.4m USD
Cost of Revenue
-51.7m USD
Gross Profit
70.6m USD
Operating Expenses
-118.8m USD
Operating Income
-48.2m USD
Other Expenses
15.8m USD
Net Income
-32.3m USD

Free Cash Flow Analysis
Quanterix Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

QTRX Profitability Score
Profitability Due Diligence

Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
26/100
Profitability
Score

Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

QTRX Solvency Score
Solvency Due Diligence

Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QTRX Price Targets Summary
Quanterix Corp

Wall Street analysts forecast QTRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QTRX is 33.66 USD with a low forecast of 31.31 USD and a high forecast of 36.75 USD.

Lowest
Price Target
31.31 USD
70% Upside
Average
Price Target
33.66 USD
83% Upside
Highest
Price Target
36.75 USD
100% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

QTRX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

QTRX Price
Quanterix Corp

1M 1M
-30%
6M 6M
-10%
1Y 1Y
+33%
3Y 3Y
-71%
5Y 5Y
-17%
10Y 10Y
+5%
Annual Price Range
18.37
52w Low
11.67
52w High
28.66
Price Metrics
Average Annual Return 5.45%
Standard Deviation of Annual Returns 65.87%
Max Drawdown -92%
Shares Statistics
Market Capitalization 698.3m USD
Shares Outstanding 38 063 600
Percentage of Shares Shorted 3.41%

QTRX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Quanterix Corp Logo
Quanterix Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

698.3m USD

Dividend Yield

0%

Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.

Contact

MASSACHUSETTS
Billerica
900 Middlesex Tpke
+16173019400.0
https://www.quanterix.com/

IPO

2017-12-07

Employees

460

Officers

President, CEO & Director
Dr. Masoud Toloue Ph.D.
Co-Founder, Chairman of Scientific Advisory Board & Independent Director
Dr. David R. Walt Ph.D.
Senior Vice President of Strategic Partnerships
Dr. Mark T. Roskey Ph.D.
Executive Director of Finance
Mr. Michael A. Doyle
Chief Financial Officer
Ms. Vandana Sriram CPA
Chief Operating Officer
Mr. Daniel Pikora
Show More
Senior VP of Research & Development and CTO
Dr. David C. Duffy Ph.D.
Senior VP & Chief Information Officer
Ms. Alexandra Phillips
Senior VP, General Counsel & Secretary
Ms. Laurie A. Churchill
Vice President of Sales
David Panzerella
Show Less

See Also

Discover More
What is the Intrinsic Value of one QTRX stock?

The intrinsic value of one QTRX stock under the Base Case scenario is 26.58 USD.

Is QTRX stock undervalued or overvalued?

Compared to the current market price of 18.37 USD, Quanterix Corp is Undervalued by 31%.